Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Freissmuth

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Acta Medica Austriaca|January 1, 1990
[Are mutations of GsAlpha the cause of thyroid autonomy?]M Hermann, E Selzer, W Schütz, et al.
European Journal of Pharmacology|September 3, 1984
Interaction of the antihypertensive drug urapidil with cardiac beta-adrenoceptors in vitroM Freissmuth, E Tuisl, G Steurer, et al.
Methods in Enzymology|January 1, 1991
Purification of recombinant Gs alphaM P Graziano, M Freissmuth, A G Gilman
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 1, 1986
Cardiac sarcolemmal purity is essential for the verification of adenylate cyclase inhibition via A1-adenosine receptorsW Schütz, M Freissmuth, V Hausleithner, et al.
Plastic and Reconstructive Surgery|April 1, 1994
Reconstructive surgery after hemilaryngectomy for recurrent thyroid cancer using a free jejunal patch-graftM Hermann, H Piza-Katzer, M Freissmuth, et al.
The Journal of Biological Chemistry|August 28, 1999
Activation of mitogen-activated protein kinase by the A(2A)-adenosine receptor via a rap1-dependent and via a p21(ras)-dependent pathwayM G Seidel, M Klinger, M Freissmuth, et al.
The Biochemical Journal|June 1, 1992
Gi3 does not contribute to the inhibition of adenylate cyclase when stimulation of an alpha 2-adrenergic receptor causes activation of both Gi2 and Gi3S J McClue, E Selzer, M Freissmuth, et al.
Trends in Pharmacological Sciences|June 15, 1999
G protein antagonistsM Freissmuth, M Waldhoer, E Bofill-Cardona, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 17, 1998
Stimulation of natural killer activity in peripheral blood lymphocytes of healthy donors and melanoma patients in vitro: synergism between interleukin (IL)-12 and IL-15 or IL-12 and IL-2M G Seidel, M Freissmuth, H Pehamberger, et al.
The Journal of Biological Chemistry|March 5, 1993
Amphipathic alpha-helical structure does not predict the ability of receptor-derived synthetic peptides to interact with guanine nucleotide-binding regulatory proteinsT Voss, E Wallner, A P Czernilofsky, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Acta Medica Austriaca|January 1, 1990
[Are mutations of GsAlpha the cause of thyroid autonomy?]M Hermann, E Selzer, W Schütz, et al.
European Journal of Pharmacology|September 3, 1984
Interaction of the antihypertensive drug urapidil with cardiac beta-adrenoceptors in vitroM Freissmuth, E Tuisl, G Steurer, et al.
Methods in Enzymology|January 1, 1991
Purification of recombinant Gs alphaM P Graziano, M Freissmuth, A G Gilman
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 1, 1986
Cardiac sarcolemmal purity is essential for the verification of adenylate cyclase inhibition via A1-adenosine receptorsW Schütz, M Freissmuth, V Hausleithner, et al.
Plastic and Reconstructive Surgery|April 1, 1994
Reconstructive surgery after hemilaryngectomy for recurrent thyroid cancer using a free jejunal patch-graftM Hermann, H Piza-Katzer, M Freissmuth, et al.
The Journal of Biological Chemistry|August 28, 1999
Activation of mitogen-activated protein kinase by the A(2A)-adenosine receptor via a rap1-dependent and via a p21(ras)-dependent pathwayM G Seidel, M Klinger, M Freissmuth, et al.
The Biochemical Journal|June 1, 1992
Gi3 does not contribute to the inhibition of adenylate cyclase when stimulation of an alpha 2-adrenergic receptor causes activation of both Gi2 and Gi3S J McClue, E Selzer, M Freissmuth, et al.
Trends in Pharmacological Sciences|June 15, 1999
G protein antagonistsM Freissmuth, M Waldhoer, E Bofill-Cardona, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 17, 1998
Stimulation of natural killer activity in peripheral blood lymphocytes of healthy donors and melanoma patients in vitro: synergism between interleukin (IL)-12 and IL-15 or IL-12 and IL-2M G Seidel, M Freissmuth, H Pehamberger, et al.
The Journal of Biological Chemistry|March 5, 1993
Amphipathic alpha-helical structure does not predict the ability of receptor-derived synthetic peptides to interact with guanine nucleotide-binding regulatory proteinsT Voss, E Wallner, A P Czernilofsky, et al.
Pageof 9